Suicide Prevention in COVID-19 Era

JAMA Psychiatry

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, OCTOBER 16, 2020

Media advisory: The full article is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2020.3746?guestAccessKey=07686aee-1fec-4329-a0fb-17e695acd6ff&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=101620

 

What The Article Says: COVID-19 presents a new and urgent opportunity to focus political will, federal investments, and global community on the vital imperative of suicide prevention. Suicide prevention in the COVID-19 era requires addressing not only pandemic-specific suicide risk factors, but also prepandemic risk factors.

Authors: Christine Moutier, M.D., of the American Foundation for Suicide Prevention in New York, is the corresponding author.

 

(doi:10.1001/jamapsychiatry.2020.3746)

Editor’s Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.